Cargando…

Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China

Objective: The present study aims to assess the willingness to pay (WTP) for and willingness to vaccinate (WTV) with the Coronavirus (COVID-19) vaccine booster dose in China when the pandemic is under adequate control and the majority of the population is vaccinated. This study is also to identify s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hui Jun, Pan, Lei, Shi, Hui, Luo, Ji Wei, Wang, Pei, Porter, Hannah K., Bi, Ye, Li, Minghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530802/
https://www.ncbi.nlm.nih.gov/pubmed/36204240
http://dx.doi.org/10.3389/fphar.2022.1013485
_version_ 1784801760694501376
author Zhou, Hui Jun
Pan, Lei
Shi, Hui
Luo, Ji Wei
Wang, Pei
Porter, Hannah K.
Bi, Ye
Li, Minghui
author_facet Zhou, Hui Jun
Pan, Lei
Shi, Hui
Luo, Ji Wei
Wang, Pei
Porter, Hannah K.
Bi, Ye
Li, Minghui
author_sort Zhou, Hui Jun
collection PubMed
description Objective: The present study aims to assess the willingness to pay (WTP) for and willingness to vaccinate (WTV) with the Coronavirus (COVID-19) vaccine booster dose in China when the pandemic is under adequate control and the majority of the population is vaccinated. This study is also to identify significant factors associated with the WTP. Methods: This was a cross-sectional study on adults with no past or present COVID-19 infection. An online questionnaire was distributed to collect data on vaccination status, quarantine experience, and factors related to health beliefs on vaccination. The WTV was assessed through the vaccination preference. The WTP was examined by payment scale (PS) and iterative bidding game (IBG) administered in random order. Three IBG algorithms with different starting-price were presented randomly. The average WTP of PS and IBG were analyzed as primary outcomes using univariate and multivariate analyses. Multivariate ordered logistic regression was performed to identify significant factors for the WTP. Results: The survey recruited 543 participants with a mean age of 32 years and 57.80% being female. The WTV rate was 86.74%, while 94.66% of participants completed full-schedule or enhanced vaccination. The mean WTP was CNY 149 (±CNY 197) and the median WTP was CNY 80. Regarding significant factors for the WTP, urban residents were 57% more likely (95% CI: 1.11-2.22) to pay for a high-priced vaccine than rural residents. Respondents who completed full-schedule vaccination were 46% more likely (95% CI: 1.03–2.07) to pay for a high-priced vaccine than those who completed enhanced vaccination. Respondents with a low household income of CNY 40k or lower were 62% less likely (95% CI: 0.21–0.66) to pay for a high-priced vaccine than those with a middle household income of CNY 110k–210k. Other significant factors associated with the WTP included the perceived benefit of vaccination and peer environmental pressure in the health belief model. Conclusion: The WTV with the COVID-19 vaccine booster dose was high in China. The WTP was influenced by the place of residence, vaccination status, household income, perceived benefit of vaccination, and environmental peer pressure. Study findings can inform policymakers to better design vaccination programs and financial schemes involving out-of-pocket payments.
format Online
Article
Text
id pubmed-9530802
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95308022022-10-05 Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China Zhou, Hui Jun Pan, Lei Shi, Hui Luo, Ji Wei Wang, Pei Porter, Hannah K. Bi, Ye Li, Minghui Front Pharmacol Pharmacology Objective: The present study aims to assess the willingness to pay (WTP) for and willingness to vaccinate (WTV) with the Coronavirus (COVID-19) vaccine booster dose in China when the pandemic is under adequate control and the majority of the population is vaccinated. This study is also to identify significant factors associated with the WTP. Methods: This was a cross-sectional study on adults with no past or present COVID-19 infection. An online questionnaire was distributed to collect data on vaccination status, quarantine experience, and factors related to health beliefs on vaccination. The WTV was assessed through the vaccination preference. The WTP was examined by payment scale (PS) and iterative bidding game (IBG) administered in random order. Three IBG algorithms with different starting-price were presented randomly. The average WTP of PS and IBG were analyzed as primary outcomes using univariate and multivariate analyses. Multivariate ordered logistic regression was performed to identify significant factors for the WTP. Results: The survey recruited 543 participants with a mean age of 32 years and 57.80% being female. The WTV rate was 86.74%, while 94.66% of participants completed full-schedule or enhanced vaccination. The mean WTP was CNY 149 (±CNY 197) and the median WTP was CNY 80. Regarding significant factors for the WTP, urban residents were 57% more likely (95% CI: 1.11-2.22) to pay for a high-priced vaccine than rural residents. Respondents who completed full-schedule vaccination were 46% more likely (95% CI: 1.03–2.07) to pay for a high-priced vaccine than those who completed enhanced vaccination. Respondents with a low household income of CNY 40k or lower were 62% less likely (95% CI: 0.21–0.66) to pay for a high-priced vaccine than those with a middle household income of CNY 110k–210k. Other significant factors associated with the WTP included the perceived benefit of vaccination and peer environmental pressure in the health belief model. Conclusion: The WTV with the COVID-19 vaccine booster dose was high in China. The WTP was influenced by the place of residence, vaccination status, household income, perceived benefit of vaccination, and environmental peer pressure. Study findings can inform policymakers to better design vaccination programs and financial schemes involving out-of-pocket payments. Frontiers Media S.A. 2022-09-20 /pmc/articles/PMC9530802/ /pubmed/36204240 http://dx.doi.org/10.3389/fphar.2022.1013485 Text en Copyright © 2022 Zhou, Pan, Shi, Luo, Wang, Porter, Bi and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhou, Hui Jun
Pan, Lei
Shi, Hui
Luo, Ji Wei
Wang, Pei
Porter, Hannah K.
Bi, Ye
Li, Minghui
Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
title Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
title_full Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
title_fullStr Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
title_full_unstemmed Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
title_short Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
title_sort willingness to pay for and willingness to vaccinate with the covid-19 vaccine booster dose in china
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530802/
https://www.ncbi.nlm.nih.gov/pubmed/36204240
http://dx.doi.org/10.3389/fphar.2022.1013485
work_keys_str_mv AT zhouhuijun willingnesstopayforandwillingnesstovaccinatewiththecovid19vaccineboosterdoseinchina
AT panlei willingnesstopayforandwillingnesstovaccinatewiththecovid19vaccineboosterdoseinchina
AT shihui willingnesstopayforandwillingnesstovaccinatewiththecovid19vaccineboosterdoseinchina
AT luojiwei willingnesstopayforandwillingnesstovaccinatewiththecovid19vaccineboosterdoseinchina
AT wangpei willingnesstopayforandwillingnesstovaccinatewiththecovid19vaccineboosterdoseinchina
AT porterhannahk willingnesstopayforandwillingnesstovaccinatewiththecovid19vaccineboosterdoseinchina
AT biye willingnesstopayforandwillingnesstovaccinatewiththecovid19vaccineboosterdoseinchina
AT liminghui willingnesstopayforandwillingnesstovaccinatewiththecovid19vaccineboosterdoseinchina